On April 24, an article in the MIT Technology Review described immediate concerns over the Wisconsin/WARF/Thomson patent on stem cells because of how the patent would affect basic academic research, which, in turn, could affect the development of stem cell-based devices and therapies.
The article mentions steps that the state of California might take to ensure collaboration among researchers from different states. The California CIRM oversight committee recently announced that any California researcher who develops a patented invention using California state funds must share their patent with other state researchers. Ed Penhoet of CIRM was quoted: “We hope WARF will retaliate.
” Of course, one problem is that WARF currently has patents related to embryonic stem cells, and CIRM does not. Next, people need to know the details of what is being shared. Does the division only apply to use by researchers in academic institutions, or does it extend to … Read More